clinical trial · NCT07592572
A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants
Eli Lilly and Company·phase1·completed·n = 14
HealthyLY4395089ItraconazoleItraconazole
brief summary
The purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical research unit (CRU). The study will last about 2 weeks.
started
May 20, 2026
primary completion
Jul 8, 2026
completion
Jul 8, 2026
last updated
Aug 25, 2026
official title
A Phase 1, Open-Label, Fixed-Sequence Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of LY4395089 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol